Director dealings: One Health Group director raises stake.


One Health Group revealed on Wednesday that non-executive director Zak McMurray had acquired 39,840 ordinary shares in the AIM-listed provider of NHS-funded surgical procedures.

  • One Health Group
  • 22 July 2026 15:35:25

Source: Sharecast

McMurray, who joined One Health Group in May 2021, purchased the shares on Tuesday at an average price of 251p each, for a total value of £99,998.40.

Following the transaction, McMurray holds a beneficial interest in 53,173 ordinary One Health shares, representing 0.38% of the company's issued share capital.

As of 1535 BST, One Health shares were up 0.70% at 250.25p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

One Health Group (OHGR)
Director name: McMurray,Zachary William
Amount purchased: 39,840 @ 251.00p
Value: £99,998.40

Dp Poland (DPP)
Director name: Glebocki,Przemyslaw
Amount purchased: 612,000 @ 6.86p
Value: £41,983.20

Hercules (HERC)
Director name: Tedham ,Martin
Amount purchased: 50,000 @ 32.00p
Value: £16,000.00

Proservice Building Services Marketplace (PRO)
Director name: Shorten,Tom
Amount purchased: 639,466 @ 2.20p
Value: £14,068.25

Pets At Home Group (PETS)
Director name: `Jane,Natalie
Amount purchased: 2,525 @ 197.58p
Value: £4,988.90

Top Director Sells


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.